6 ms·
Oncological Virus, or OV. Pushing science fiction. But did Washington Post forget to mention the 2nd patient they released data on, who didn't have any kind of
by zaroth 13y ago
Oncological Virus, or OV. Pushing science fiction. But did Washington Post forget to mention the 2nd patient they released data on, who didn't have any kind of prolonged response?
The paper presents 2 cases, selected because they were the first 2 cases to be tested at maximum viral load. There are additional people in the trial, and they will release full results once they are available.
It included two slides showing before/after blood levels and imaging. They talk about how they modified the virus to emit a tracking signal, and how they modified it to target the cancer cells. Really, really mind blowing and impressive work. I would love a tour of that lab.
These are end-stage patients for whom everything else has stopped working. One of the patients had already undergone several experimental treatments. There is some really exciting research going on for MM (multiple myeloma) treatments, and maybe even cures.
I think this is one example of the free market working well. Typical MM treatment runs about $60k / year, and with recent developments, patients are living 10+ years. Total number of MM patients is increasing both because the disease is becoming more prevalent, but mostly because people are living so much longer with MM. In short, it's a large and growing market. But it's not a cancer you can treat and have it go into remission. You get on treatment, and you stay on it and keep those levels down. The typical treatment is biweekly therapy.
But these OVs are one-time deals. So a single dose treatment is a very interesting alternative. The only problem is, MM is extremely resilient, and the cells are everywhere. It's so hard to eradicate, unless the OV is a cure, it's just another tool in the box to manage MM and extend lives.
Weird, the PDF of the actual paper was freely downloadable a couple hours ago, but now it seems the paywall is up? http://www.sciencedirect.com/science/article/pii/S0025619614003322 http://www.sciencedirect.com/science/article/pii/S0025619614...
- ekianjo 13y ago> But these OVs are one-time deals. So a single dose treatment is a very interesting alternative. The only problem is, MM is extremely resilient, and the cells are everywhere. It's so hard to eradicate, unless the OV is a cure, it's just another tool in the box to manage MM and extend lives. Yes, the key point to watch next is to see if the MM does not come back after a couple of years.
- zaroth 13y agoThe virus is gone from her system. The MM is not at undetectable levels. So unfortunately, this OV is not a cure. This particular patient, her MM cells aren't surging just yet. I think the curative approach will ultimately come from immunotherapy, training the body to attack the cells. OV could certainly have it's place, for example as an alternative to ASCT.
- ercu 13y ago>I think the curative approach will ultimately come from immunotherapy, training the body to attack the cells. As i know, just killing the cancer cells is not enough. The real curative treatment is to kill cancer stem cells using drugs. http://www.survivingmesothelioma.com/news/view.asp?ID=001532 http://www.survivingmesothelioma.com/news/view.asp?ID=001532
- im3w1l 13y agoOne thing I don't understand is this attitude of "well we can't detect it, so job is done". I don't know the specifics of detectability, but presumably it means that n<N for some N. So there could still be some cells left. Why not throw every weapon in the arsenal at them, to ensure the cancer is completely gone? EDIT, addendum: If you have a few treatments that each can kill 9999/10000 cancer cells. It seems the current approach is apply treatment a. Not detectable yay! They grow back to original numbers. Apply treatment b! etc. If you did them all at once, they wouldn't have time to grow back in-between treatments giving a larger chance you get them all.
- DanBC 13y agoBecause some weapons in the arsenal will be killing the patient as well as killing any possible cancer cells. At some point the risks of the treatments outweigh the risks of leaving some cells.
- DaveWalk 13y agoThis is correct. As a matter of fact, even dosing one chemotherapy may be a challenge for a patient if the side effects are too server (lowered immune resistance, can't keep food down, etc). We're talking about drugs with such small therapeutic windows that given too often can easily kill a healthy human.
- samirmenon 13y agoHere's the full text I found: http://www.mayoclinicproceedings.org/article/S0025-6196(14)00332-2/fulltext http://www.mayoclinicproceedings.org/article/S0025-6196(14)0...
- barbs 13y ago> But did Washington Post forget to mention the 2nd patient they released data on, who didn't have any kind of prolonged response? They mentioned the second patient in the article: The trial included two patients. Russell said the treatment worked in Erholtz, whose tumors were mostly in her bone marrow. However, it was unsuccessful in the other patient, whose tumors were mainly in her leg muscles, the Star-Tribune reported. He said more research is needed to know how the nature of the tumor affects the virus.
- lingben 13y agowait, what? I'm not an oncologist but I read that muscles are the one tissue or place in our body which does not get cancer - this has to do with the way muscles are so 'greedy' for blood vessels that they do not allow angiogenesis to cancer cells.
- robinh 13y agoSadly not: http://en.wikipedia.org/wiki/Sarcoma http://en.wikipedia.org/wiki/Sarcoma
- adinb 13y agoIn the video at the mayo clinic site they talk a bit more about patient 2. While not all tumors were destroyed, they were fully mapped due to compounds from the thyroid being attached to the virus, implying that localized treatment would then be possible. http://www.mayoclinicproceedings.org/article/S0025-6196(14)00332-2/fulltext http://www.mayoclinicproceedings.org/article/S0025-6196(14)0... Editorial Article: http://www.mayoclinicproceedings.org/article/S0025-6196(14)00368-1/fulltext http://www.mayoclinicproceedings.org/article/S0025-6196(14)0...
- deepakprakash 13y agoMy dad has been a MM patient for close to 6 years now and you are spot-on about the disease's general behaviour.. We started with Lenalidomide and was on it until end of last year with breaks of up to 6-8 months where there was no specific meds.. He's now on a Bortezomib cycle which will end in a couple of months and we hope to have some months free of meds again.. We never did the bone marrow transplant considering his age and stress/recovery he would have to go through.. MM is sympathetic in the sense that people who respond to meds can have a high quality of life even while undergoing treatment (my dad is still a practising medical Doctor). Lenalidomide is a tablet that you take at home while you go in once every week or two for Bortezomib shots.. The treatment is also considerably cheaper in India (still not inexpensive by any measure).. The overarching fear for MM patients is the fact that its indeed incurable and how far/long we can go on before running out of treatment options.. Personally, seeing such trials and success gives us hope and comfort.. OV looks a promising approach and I hope my dad and others will be able to benefit from it..
- zenbuzzfizz 13y agoSorry to hear about your dad's illness. MM is a bitch. If coming to the US is an option, there is a treatment center (Myeloma Institute for Research and Therapy MIRT) that is part of the University of Arkansas and is probably one of the best places in the world to get myeloma treatment. I know quite a number of people that have gone there and gotten good results. It is based in Little Rock (of all unlikely places) I think because it was founded by a grant from Sam Walton, founder of WalMart. He died from MM in 1992.
- robbiep 13y agoAll haematological cancers are everywhere. The bizarre thing is, despite their outrageously disseminated nature, many haematological cancers now have amongst the best prognoses (at least in certain age groups).
- chockablock 13y ago> I think this is one example of the free market working well. How so? While I'm sure the Mayo Clinic will be attempting to patent and license this therapy, the research was apparently funded by the US government and various philanthropies. [Quoting relevant sections of the paper since the full text is paywalled.] "Grant Support: This work was supported by funds from the National Institutes of Health/National Cancer Institute (grants R01CA125614 and R01CA168719), Al and Mary Agnes McQuinn, the Harold W. Siebens Foundation, and the Richard M. Schulze Family Foundation. The National Cancer Institute RAID (Rapid Access to Intervention Development) Program supported MV-NIS manufacture and toxicology/pharmacology studies. Potential Competing Interests: Drs Russell, Federspiel, and Peng and Mayo Clinic have a financial interest in the technology used in this research."
- zaroth 13y agoI don't really know any hard numbers, but you have to imagine, getting this OV to market would be extremely expensive. Public funds only cover a small portion of the costs of the early research. Large scale phase 3 trials will be funded by the drug company expecting to profit off it. If public funds and private donations could actually cover the research costs getting all the way to FDA approval, I would think you would see more doctors and researchers creating nonprofit partnerships to attract the funds and do the research. Sounds like it would be a dream come true to be funded to do research you cared about and better the lives of millions without the corporate suits getting in your way. But I think the reality is the facilities alone cost hundreds of millions if not billions, so just for Mayo to give you the lab space to work for a couple years is a major investment.
- bradleyjg 13y agoPublic funds will end up paying for a large portion of those phase 3 trials because the biggest customer of the those drug companies will be government programs. If the trial is not successful that the government will still pay a large portion via increased prices for other drugs. (Plus there's forgone income via the extensive tax subsidies for health care spending.) I don't know why we go through this kabuki process of pretending there is a functioning market in places where the government is such a dominant player (see also defense contractors). Why not just cut out the middleman?
- coldtea 13y ago>I think this is one example of the free market working well. Well Fleming (who discovered antibiotics) was working for the (British) government, so if the above is in any way an indication of "the free market working well", then his extremely more important results were an example of public sponsored research working great.
- lostlogin 13y agoCould you explain how this is an example of the free market working well? Clearly this is leading edge medicine but the free market thing escapes me.
- zaroth 13y agoIf you take a look at the list of new MM therapies hitting the market in just the last 5 years, and the number that are in the pipeline, you can see there has been a surge of investment in MM treatments, when for years the only options were dex and ASCT. I think all this investment has been bolstered by the market success that Revlimid and Velcade are seeing. These drugs are cheap to produce, sell for about $5k per weekly or biweekly dose, and that a large and growing number of people are very happy to pay for, because they are well tolerated for as long as they work. Revlimid is just a pill you take, Velcade is a shot in the arm, so both are very cheap to administer. There is huge incentive to keep producing more of these MM treatments, because the MM becomes refractory to each successive therapy over time. If you can make a good first-line treatment which is effective for 3 years on average, that's more than $100k per patient, at what, 90% gross margin? I don't mean "free market" in the libertarian sense. I mean it in the sense that investment capital follows investment opportunity, and we are definitely seeing that here.
- lostlogin 13y agoI can't get past the fact that people almost certainly aren't paying for it. Insurance companies must be as very few could afford those costs. As many can't afford insurance, it's more like the free(ish) market. Thanks for your reply, I see what you mean now.